MPX International (XCNQ:MPXI) Common Stock : C$66.43 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is MPX International Common Stock?

MPX International's quarterly common stock stayed the same from Sep. 2021 (C$66.40 Mil) to Dec. 2021 (C$66.40 Mil) but then increased from Dec. 2021 (C$66.40 Mil) to Mar. 2022 (C$66.43 Mil).

MPX International's annual common stock increased from Sep. 2019 (C$63.60 Mil) to Sep. 2020 (C$66.14 Mil) and increased from Sep. 2020 (C$66.14 Mil) to Sep. 2021 (C$66.40 Mil).

MPX International Common Stock Historical Data

The historical data trend for MPX International's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Common Stock Chart

MPX International Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Common Stock

63.60

66.14

66.40

MPX International Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Common Stock	Get a 7-Day Free Trial												66.40	66.40	66.40	66.40	66.43

MPX International Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

MPX International (XCNQ:MPXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (XCNQ:MPXI) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4

Website

https://www.mpxinternationalcorp.com

MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

Executives

William Scott Boyes	Director, Senior Officer
Randall Glenn Stafford	Director

MPX International (XCNQ:MPXI) Headlines

No Headlines